about
Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicinePrecision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & ImmunologyNovel developments in the mechanisms of immune tolerance to allergensIdentification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific FabA second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epiderT cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthmaImmunological mechanisms of allergen-specific immunotherapyWe Call for iCAALL: International Collaboration in Asthma, Allergy and ImmunologyMechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes.Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy.EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.Specific immunotherapy and turning off the T cell: how does it work?The biodiversity hypothesis and allergic disease: world allergy organization position statement.TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritisRORC2 is involved in T cell polarization through interaction with the FOXP3 promoter.GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema.Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cellsNature of regulatory T cells in the context of allergic disease.Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis.IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.T-cell subset regulation in atopy.Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled airImmunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms.IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.Immune regulation by histamine.Expression of genes related to anti-inflammatory pathways are modified among farmers' children.Mechanisms of immune tolerance to allergens: role of IL-10 and TregsHistamine in the immune regulation of allergic inflammation.The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses.Mechanisms of specific immunotherapy: current knowledge.T regulatory cells in allergy and health: a question of allergen specificity and balance.Apoptosis in tissue inflammation and allergic disease.An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.Histamine in allergic inflammation and immune modulation.
P50
Q26747302-C9154B9F-E7A0-4314-96C2-2A50EE39A9D4Q26751386-73A6DFD6-0EDD-49F2-A678-ACD2BECC22F7Q27025655-BE5FCB14-2F75-4A95-AC7E-EFFAD262470BQ27644160-47B9F03A-E71A-4118-8107-2402C8D30569Q28185664-33200CCC-7996-4FBD-80F7-8730C1F2336BQ28201095-FE7E7D0C-011F-44C5-AABE-94233E550A47Q28265326-45BFA36E-3AD8-4459-9D64-F4C35145A7B9Q28710511-752A526D-D772-4938-A2A9-0C2467A1B5C1Q30238498-AD8EECB0-B0FE-4BBC-A89B-AD6A1222229CQ30379864-F1D0A466-6A03-48FD-AB26-6EF013EA4CE6Q30394524-E818C645-8C3F-418D-B166-D062367BCA51Q30485173-CFCDEB5F-A3B4-4359-8651-DB0BE63C61D2Q30624202-0478A3FA-0F35-4722-8A64-081E269C709DQ30988219-907A1E0E-1A6D-417E-BC3F-35F5BC5037F8Q31814845-85266AF2-028B-4831-A81E-935C811AEA22Q33312509-6A8E67CF-06F2-46CC-B963-C68789A7ABD4Q33471046-DD804B1F-1303-4F51-8080-D0DDFD270B84Q33591090-54070DFA-B01E-4D91-ACF2-23A6A5B83DF1Q33846653-95C7FADF-B4C0-4014-A221-4A502B6E8A60Q34137298-2291D3E2-6319-427D-AB2C-0FB677A519DEQ34165569-86B9BC53-F9F3-4E1C-93AB-D6E9D3B06092Q34168692-604D095D-F47A-4933-82A5-C39932BF79F5Q34263412-C35B0767-685E-4653-9F69-263E2F215197Q34330562-9B0C880E-E1E9-4E2A-BFF3-6136630F7BAFQ34548321-D8B6EEED-CE2A-4624-9490-A330716D5C64Q34617024-B3B48D04-E1F8-43B3-96F6-CECC3C85123BQ34687384-764ADE00-3645-4981-BCF1-3E1B88641F2BQ34737261-9E7410D9-BC11-4C49-9EA5-F77ACA42980BQ34987195-B593DEBA-2A3A-49E0-8DC7-828263C88B3CQ34987280-D96510CF-1F73-451A-8B41-D9AA0A3D4550Q35113034-35B6EB69-F62A-4959-A6D5-AA77621CD905Q35140130-201B11BB-CB86-4FBF-863A-CB3D21277DEAQ35171180-0B9CE510-8B9A-4434-97A3-BF1BCDF0DB21Q35620005-8E3394F9-8F6D-483D-AEAF-DA07A286C054Q35760878-61C45C06-2155-4FB5-A411-532C73374FECQ35875954-A3731C0A-5EF1-47E9-B985-64279431501CQ35931532-E88C0864-1C64-4543-B885-2CA064477649Q35945273-A77718A6-FC90-4A8B-9E1B-B84EF20154D0Q36096729-A466EA82-2E6A-47FE-96D9-11B66B1CD5BEQ36098788-0026724F-1B18-4795-BE62-BB9095989A20
P50
name
Cezmi A Akdis
@en
type
label
Cezmi A Akdis
@en
prefLabel
Cezmi A Akdis
@en